miR-26a Suppresses Tumor Growth and Metastasis by Targeting FGF9 in Gastric Cancer

100 PRDM1 is the Causal Gene in a CD Susceptibility Locus Identified via GWAS on 6q21

(2015) Hu Zhang et al.   GASTROENTEROLOGY

MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma

(2013) Hao Yang et al.   HEPATOLOGY

miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma

(2013) Min Deng et al.   TUMOR BIOLOGY

The Duality of OncomiR Addiction in the Maintenance and Treatment of Cancer

(2012) Christopher J. Cheng et al.   CANCER JOURNAL

MicroRNAs: New tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?

(2012) Silvia Giordano et al.   HEPATOLOGY

Meta-analysis of microRNA expression in lung cancer

(2012) Urmo Võsa et al.   INTERNATIONAL JOURNAL OF CANCER

Loss ofmiR-101expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells

(2012) Antonio Strillacci et al.   JOURNAL OF PATHOLOGY

MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein

(2012) Ying Zhu et al.   NUCLEIC ACIDS RESEARCH

Trastuzumab Produces Therapeutic Actions by Upregulating miR-26a and miR-30b in Breast Cancer Cells

(2012) Takehiro Ichikawa et al.   PLoS One

miR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia

(2012) X. Jiang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)

(2011) U. Ralfkiaer et al.   BLOOD

MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2

(2011) J. Lu et al.   CANCER RESEARCH

Deregulated expression of miR-26a and Ezh2 in Rhabdomyosarcoma

(2011) Roberta Ciarapica et al.   CELL CYCLE

miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma

(2011) Min Deng et al.   JOURNAL OF CELL SCIENCE

Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases

(2011) T Papagiannakopoulos et al.   ONCOGENE

Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101 and miR-98

(2011) N M Alajez et al.   Cell Death & Disease

MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2

(2010) Ling Ding et al.   CELL RESEARCH

MiR-218 Inhibits Invasion and Metastasis of Gastric Cancer by Targeting the Robo1 Receptor

(2010) Jun Tie et al.   PLoS Genetics

MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma

(2009) H-C Chen et al.   BRITISH JOURNAL OF CANCER

The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo

(2009) J. T. Huse et al.   GENES & DEVELOPMENT

Genetic dissection of the miR-17 92 cluster of microRNAs in Myc-induced B-cell lymphomas

(2009) P. Mu et al.   GENES & DEVELOPMENT

Survival prediction of gastric cancer by a seven-microRNA signature

(2009) X. Li et al.   GUT

Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis

(2009) Tetsuya Ueda et al.   LANCET ONCOLOGY

MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer

(2009) Junfang Ji et al.   NEW ENGLAND JOURNAL OF MEDICINE

miRiad Roles for the miR-17-92 Cluster in Development and Disease

(2008) Joshua T. Mendell   CELL

MicroRNA in Cancer Prognosis

(2008) Frank J. Slack et al.   NEW ENGLAND JOURNAL OF MEDICINE

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

(2008) L.-X. Yan et al.   RNA